59.04
-2.11
(-3.45%)
At close: April 17 at 5:35:43 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 18 | 18 | 25 | 23 |
Avg. Estimate | 93.35B | 95.08B | 389.18B | 407.67B |
Low Estimate | 91.26B | 92.91B | 382.24B | 386.86B |
High Estimate | 98B | 97.65B | 399.28B | 424.83B |
Year Ago Sales | 88.44B | 91.23B | 372.81B | 389.18B |
Sales Growth (year/est) | 5.55% | 4.21% | 4.39% | 4.75% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CVS.DE | -- | -- | -- | -- |
S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
Maintains | Baird: Neutral to Neutral | 4/15/2025 |
Maintains | Truist Securities: Buy to Buy | 4/11/2025 |
Maintains | Mizuho: Outperform to Outperform | 4/9/2025 |
Maintains | Piper Sandler: Overweight to Overweight | 3/21/2025 |
Maintains | JP Morgan: Overweight to Overweight | 2/18/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 2/13/2025 |